GlassScriptPhysician profile
Anna X Tsai
NPI 1578880290
$3,321.79
in general payments reported to CMS, 2019-2025
15 companies · $72.65 in 2025
The $72.65 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $971 · 2020: $17.25 · 2021: $247 · 2022: $562 · 2023: $853 · 2024: $599 · 2025: $72.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,524.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $962.98 | 2019-2022 | |
| Inspire Medical Systems, INC. | $468.92 | 2022-2023 | Inspire |
| Cochlear Americas | $395.62 | 2019-2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
| Optinose US, INC. | $278.15 | 2020-2023 | |
| Aerin Medical INC. | $248.68 | 2023-2024 | |
| Medtronic, INC. | $241.48 | 2022-2023 | Sinuva |
| Smith+Nephew, INC. | $227.05 | 2019-2024 | Tula |
| Stryker Corporation | $185.23 | 2021-2023 | Xpress Ent Dilation System, Smartlock, Delta |
| Livanova USA, INC. | $166.84 | 2023-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Regeneron Healthcare Solutions, INC. | $52.15 | 2022 | |
| Glaxosmithkline, LLC. | $25.59 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.82 | 2022 | |
| Advanced Bionics, LLC | $17.49 | 2019 | |
| Depuy Synthes Sales INC. | $15.99 | 2022 | |
| Kls-Martin L.P. | $13.80 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Tsai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.